AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment
The anaerobic digestion facility and long-term partnership with Future Biogas provide a blueprint for the commercial adoption of renewable gas in the UK.
- The anaerobic digestion facility and long-term partnership with Future Biogas provide a blueprint for the commercial adoption of renewable gas in the UK.
- A competitive biomethane market can play a key role in the transition to net zero.ii
To support the transition to clean heat in the UK, energy efficiency improvements will be made at AstraZeneca’s Macclesfield campus, the largest medicines development and manufacturing site in the UK. - AstraZeneca is on track to reduce GHG emissions from its global operations (Scope 1 and 2) by 98% by 2026.
- This latest commitment to renewable energy in the UK follows other innovative partnerships announced earlier this year.